Dipeptidyl peptidase-4 (DPP-4), also known as CD26, is widely expressed in the epidermis and on multiple immune cell subtypes, and preclinical studies demonstrating cutaneous vasculitis in non-human primates with some, but not all, DPP-4 inhibitors [20], has heightened awareness of the potential consequences of DPP-4 inhibition on the skin
This action reflects our responsibility to protect patients and preserve the integrity of the drug approval process while continuing to provide a transparent, science-based pathway for public input. The Debate Against Compounding GLP-1s This regulatory shift occurs against a backdrop of heightened scrutiny regarding the safety and marketing of compounded GLP-1 products
Patients with commercial insurance may find coverage under their pharmacy benefit, particularly for Ozempic (approved for type 2 diabetes, widely covered) and Wegovy (obesity indication, coverage varies)
But be warned: at higher concentrations, small measuring errors produce larger dosing mistakes
Hu JL, Wu JY, Xu S, Qian SY, Jiang C, Zheng GQ